NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Lifecore Biomedical, Inc. Common Stock (LFCR)

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacture of hyaluronate acid in bulk form; and formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. It also provides product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Ticker
LFCR
Exchange
XNAS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Company profile updated October 11, 2026.

Stored market snapshot

As of October 9, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$6.45
Company market capitalization (USD)
$244,152,237
Price / book
15.17×

Research LFCR

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: